Dr. Anmin Huang, Peking university, China
Anmin Huang is a Ph.D. and M.D. candidate in Gastroenterology and Hepatology at Peking University. His research focuses on cancer immunotherapy, immune-related biomarkers, and hepatocellular carcinoma. He has authored several high-impact publications in leading journals such as ACS Applied Materials & Interfaces, Frontiers in Molecular Biosciences, and Hepatobiliary Pancreatic Diseases International, covering topics such as immune and ferroptosis-related signatures, tumor immune infiltration, and multifunctional tumor vaccines. Additionally, he has contributed to multiple patents, including innovations in apoptotic biomimetic nanoparticles for tumor immunotherapy and efficient anti-cancer tumor vaccines. His work integrates computational and experimental approaches to advance cancer treatment strategies, reflecting his expertise in translational medicine and biomedical engineering.
ORCID
Summary of Suitability for Best Researcher Award – Anmin Huang
Dr. Anmin Huang, a Ph.D./MD candidate at Peking University specializing in Gastroenterology and Hepatology, has demonstrated exceptional research contributions in the fields of cancer immunotherapy, hepatocellular carcinoma, and tumor microenvironment analysis. His groundbreaking publications, innovative patents, and impactful translational research make him a strong candidate for the Best Researcher Award.
🎓 Education & Work Experience
-
Ph.D./MD Candidate | Peking University, Major: Gastroenterology and Hepatology
-
Researcher | Specializing in immunotherapy, cancer biology, and hepatocellular carcinoma
🏆 Achievements
-
Research Publications 📚
-
Published multiple high-impact papers in ACS Applied Materials & Interfaces, Frontiers in Molecular Biosciences, Hepatobiliary Pancreatic Diseases International, and Engineering
-
Developed immune and ferroptosis-related LncRNA signatures for cancer prognosis
-
Contributed to the study of tumor immune infiltration and immunotherapy response
-
Patents & Innovations 🧪
-
Holder of two utility model patents for laboratory equipment
-
Co-inventor of apoptotic biomimetic nanoparticles for tumor immunotherapy
-
Co-inventor of an anti-cancer tumor vaccine with an innovative preparation method
🎖 Awards & Honors
Publication Top Notes:
Engineered Apoptosis-Bioinspired Nanoparticles Initiate Immune Cascade for Cancer Immunotherapy of Malignant Ascites